Quality of life predicts survival in patients with non-small cell lung cancer

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Li, Tsai Chung ^a,b   Li, Chia Ing ^a,c,d   Tseng, Chun Hua ^a   Lin, Kuan Shin ^a   Yang, Sing Yu ^a   Chen, Chih Yi ^c   Hsia, Te Chun ^c   Lee, Yih Dar ^e,f   Lin, Cheng Chieh ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e BRISTOL MYERS SQUIBB   (United States)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

HRQOL; Lung cancer; Prognostic factors; Survival

Indexed keywords

ARTICLE; COMPARATIVE STUDY; FEMALE; HEALTH STATUS INDICATOR; HUMAN; LUNG NON SMALL CELL CANCER; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE;

MLCS; MLOWN;

EID: 84866170023     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-790     Document Type: Article

References (24)

1. Annual statistics report in 2011: Republic of China from Department of Health, R.O.C, http://www.doh.gov.tw/CHT2006/DM/DM2-2.aspx?now-fod-list-no= 9510&class-no=440&level-no=1
2. Self-perceptions of health: a prospective analysis of mortality, control, and health. Menec VH, Chipperfield JG, Perry RP, J Gerontol Psychol Sci 1999 54B 2 85 93 10.1093/geronb/54B.2.P85
3. Self-rated health and survival: a 7-year follow-up study of Australian elderly. McCallum J, Shadbolt B, Wang D, Am J Public Health 1994 84 1100 1105 10.2105/AJPH.84.7.1100 8017532 (Pubitemid 24242480)
4. The meaning of older adults' health appraisals: congruence with health status and determinant of mortality. Borawski EA, Kinney JM, Kahana E, J Gerontol Soc Sci 1996 51B 157 S170 10.1093/geronb/51B.3.S157
5. Is quality of life predictive of the survival of patients with advanced non-small cell lung carcinoma? Herndon JE, Fleishman S, Kornblith AN, Kosty M, Green MR, Holland J, Cancer 1999 85 333 340 10.1002/(SICI)1097-0142(19990115)85: 2<333::AID-CNCR10>3.0.CO;2-Q 10023700 (Pubitemid 29051287)
6. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M, Radiother Oncol 2000 55 19 25 10788684 (Pubitemid 30219430)
7. Quality of life in lung cancer patients as an important prognostic factor. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR, Lung Cancer 2001 31 233 240 10.1016/S0169-5002(00)00179-3 11165402 (Pubitemid 32107019)
8. Baseline FACT-G score is a predictor of survival for advanced lung cancer. D Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D, Qual Life Res 2004 13 1209 1216 15473499 (Pubitemid 39157332)
9. Fleming ID, Cooper JS, Henso DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW, AJCC Cancer Staging Manual Philadelphia: Lippencott-Raven Publishers 5 1997
10. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F, J Natl Cancer Inst 1993 85 365 376 10.1093/jnci/85.5.365 8433390 (Pubitemid 23073154)
11. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M, Eur J Cancer 1994 30A 635 642 8080679 (Pubitemid 24164250)
12. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Chie WC, Yang CH, Hsu C, Yang PC, Qual Life Res 2004 13 257 262 15058806 (Pubitemid 38315239)
13. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL, Qual Life Res 1997 6 151 158 9161115 (Pubitemid 27207280)
14. Quality of life of cancer patients with different prognosis. Ringdal GI, Ringdal K, Kvinnsland S, Götestam KG, Qual Life Res 1994 3 143 154 10.1007/BF00435257 8044159 (Pubitemid 24162860)
15. Prognostic factors and survival in a heterogeneous sample of cancer patients. Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdal K, Br J Cancer 1996 73 1594 1599 10.1038/bjc.1996.300 8664136 (Pubitemid 26235390)
16. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Coates A, Porzsolt F, Osoba D, Eur J Cancer 1997 33 1025 1030 10.1016/S0959-8049(97)00049-X 9376182 (Pubitemid 27310776)
17. Prognostic value of performance status and quality of life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. Coates A, Forbes J, Simes RJ, J Clin Oncol 1993 11 2050 2051 8410130
18. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Kramer JA, Curran D, Piccart M, de Haes JC, Bruning P, Klijn J, Van Hoorebeeck I, Paridaens R, Eur J Cancer 2000 36 1498 1506 10.1016/S0959-8049(00)00144-1 10930797 (Pubitemid 30619002)
19. Baseline health-related quality of life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Efficace F, Biganzoli L, Piccart M, Coens C, Van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A, EORTC-BCG-IDBBC-NDDG, Eur J Cancer 2004 40 1021 1030 10.1016/j.ejca.2004.01.014 15093577 (Pubitemid 38496258)
20. The prognostic value of quality of life scores during treatment for oesophageal cancer. Blazeby JM, Brookes ST, Alderson D, Gut 2001 49 227 230 10.1136/gut.49.2.227 11454799 (Pubitemid 32675116)
21. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY, Int J Radiat Biol Phys 2004 58 1394 1404 10.1016/j.ijrobp.2003.09.100 (Pubitemid 38438299)
22. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patients data. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ, J Clin Oncol 2004 22 2395 2403 10.1200/JCO.2004.08.154 15197201 (Pubitemid 41121931)
23. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Bonnetain F, Paoletti X, Collette S, Doffoel M, Bouché O, Raoul JL, Rougier P, Masskouri F, Barbare JC, Bedenne L, Qual Life Res 2008 17 831 843 10.1007/s11136-008-9365-y 18618292
24. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA, Eur J Cancer 2001 37 332 339 10.1016/S0959-8049(00)00385-3 11239754 (Pubitemid 32182321)